Stocks and Investing Stocks and Investing
by Source: (remove) : Thomas Allen
RSSJSONXMLCSV
Tue, November 7, 2023
Thu, February 23, 2023
Mon, November 21, 2022
Mon, April 25, 2022
Fri, February 4, 2022
Tue, January 18, 2022
Wed, October 20, 2021
Mon, October 11, 2021
Mon, September 20, 2021
Wed, July 28, 2021
Tue, May 11, 2021
Mon, May 3, 2021
Wed, April 28, 2021
Mon, April 5, 2021
Tue, March 2, 2021
Mon, February 22, 2021
Wed, January 20, 2021
Thu, November 19, 2020
Fri, November 6, 2020
Mon, November 2, 2020
Tue, October 27, 2020
Fri, October 16, 2020

Thomas Allen Maintained (TMDX) at Buy with Increased Target to $70 on, Nov 7th, 2023


Published on 2024-10-28 07:23:48 - WOPRAI, Thomas Allen
  Print publication without navigation
Thomas Allen of JP Morgan, Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $67 to $70 on, Nov 7th, 2023.

Thomas has made no other calls on TMDX in the last 4 months.



There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas


  • Joshua Jennings of "TD Cowen" Maintained at Buy with Increased Target to $110 on, Friday, August 4th, 2023
Contributing Sources